CING: Cingulate Inc. Stock

by  •  • Comments Off on CING: Cingulate Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 5.38
Enterprise Value ($M) 7.27
Book Value ($M) 3.22
Book Value / Share 0.53
Price / Book 1.67
NCAV ($M) 0.45
NCAV / Share 0.07
Price / NCAV 12.00

Profitability (mra)
Return on Invested Capital (ROIC) -3.39
Return on Assets (ROA) -3.14
Return on Equity (ROE) -275.72

Liquidity (mrq)
Quick Ratio 1.21
Current Ratio 1.21

Balance Sheet (mrq) ($M)
Current Assets 2.73
Assets 5.49
Liabilities 2.28
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -22.76
Net Income -23.53

Cash Flow Statement (mra) ($M)
Cash From Operations -15.03
Cash from Investing -0.22
Cash from Financing 9.95

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-12 13D/A Werth Peter J. 19.48 0.60
02-09 13G Lind Global Fund II LP 9.90
01-04 13D/A Schaffer Shane J. 3.65 -94.62
07-25 13G/A Brams Matthew 4.70 0.24

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-10 9,553 92,503 10.33
2024-05-09 1,872 1,647 113.66
2024-05-08 3,110 3,732 83.33
2024-05-07 13,974 7,743 180.47
2024-05-06 21,216 5,942 357.05

(click for more detail)

Similar Companies
CELZ – Creative Medical Technology Holdings, Inc. CERE – Cerevel Therapeutics Holdings, Inc.
CGEN – Compugen Ltd. CKPT – Checkpoint Therapeutics, Inc.
CLDX – Celldex Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io